Page last updated: 2024-10-31

metyrapone and Anemia, Sickle Cell

metyrapone has been researched along with Anemia, Sickle Cell in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenbloom, BE1
Odell, WD1
Tanaka, KR1

Other Studies

1 other study available for metyrapone and Anemia, Sickle Cell

ArticleYear
Pituitary-adrenal axis function in sickle cell anemia and its relationship to leukocyte alkaline phosphatase.
    American journal of hematology, 1980, Volume: 9, Issue:4

    Topics: Adult; Alkaline Phosphatase; Anemia, Sickle Cell; Blood Glucose; Cortodoxone; Female; Growth Hormone

1980